Read More Analyst Color Analyst Ratings Biotech General Health Care Large Cap M&A News Rumors SVB Leerink’s Pro-forma Analysis Of Speculated Merck/Seagen Deal – What Investors Need To Know By Vandana Singh June 21, 1:25 PM SVB Securities conducted a pro-forma analysis of the financial impact to Merck & Co Inc (NYSE: MRK) from a potential acquisition of Seagen Inc (NASDAQ: SGEN). MRK
Read More Analyst Ratings Initiation News Price Target Cowen & Co. Initiates Coverage On Starry Group Holdings with Outperform Rating, Announces Price Target of $9 By Benzinga Newsdesk June 17, 9:37 AM Cowen & Co. initiates coverage on Starry Group Holdings (NYSE:STRY) with a Outperform rating and announces Price Target of $9. STRY
Read More Analyst Ratings News Price Target Keybanc Maintains Overweight on WESCO International, Raises Price Target to $130 By Benzinga Newsdesk August 24, 4:34 AM Keybanc analyst Steve Barger maintains WESCO International (NYSE:WCC) with a Overweight and raises the price target from $125 to $130. WCC
Read More Analyst Ratings Downgrades News Price Target UBS Downgrades Caterpillar to Sell, Lowers Price Target to $225 By Benzinga Newsdesk March 10, 7:37 AM UBS analyst Steven Fisher downgrades Caterpillar (NYSE:CAT) from Neutral to Sell and lowers the price target from $230 to $225. CAT